KALBITOR® (Ecallantide) Injection

KALBITOR® is a brand-name medication that contains the active ingredient ecallantide. It is primarily used to treat individuals with hereditary angioedema (HAE) by providing relief from acute attacks. KALBITOR® is a selective inhibitor of plasma kallikrein, an enzyme involved in the production of bradykinin, which plays a key role in causing swelling and inflammation in individuals with HAE.

Indications and Uses

KALBITOR® is indicated for the following purposes:

• Treatment of acute attacks of hereditary angioedema (HAE) in individuals aged 12 years and older.

• It is used to provide rapid relief from the symptoms of HAE, such as swelling and discomfort.

Dosage and Administration

The dosage of KALBITOR® is determined by a healthcare provider based on the patient's weight and specific condition. The medication is administered as a subcutaneous (under the skin) injection. It is important to use KALBITOR® as soon as an HAE attack is recognized.

Contraindications

KALBITOR® should not be used in individuals with known hypersensitivity to ecallantide or any of its components. It is essential to discuss any allergies or potential reactions with a healthcare provider.

Adverse Effects and Side Effects

Common side effects of KALBITOR® may include:

• Headache.

• Dizziness.

• Injection site reactions, such as pain and redness.

• Nausea.

Serious side effects are rare but may include:

• Anaphylactic or severe allergic reactions, which can manifest as hives, difficulty breathing, and swelling of the face, lips, or tongue.

• Hypersensitivity or immune responses.

• Risk of antibody formation against KALBITOR®.

It is crucial to report any severe or unusual side effects to your healthcare provider.

Storage and Shelf Life

Store KALBITOR® at room temperature (20-25°C or 68-77°F). Protect it from light. Do not use KALBITOR® after the expiration date.

Packaging and Presentation

KALBITOR® is available as a sterile, colorless to pale yellow solution in single-use vials for subcutaneous injection.

Regulatory Information

KALBITOR® is subject to regulation by health authorities to ensure its safety and efficacy. It is essential to use this medication as directed by a healthcare professional and in accordance with local regulations.

References

Always consult with your healthcare provider and refer to the official prescribing information and product labeling for the most up-to-date and comprehensive information on KALBITOR®. Your healthcare provider will guide you in the proper use of this medication, monitor your progress, and tailor the treatment to your specific medical condition.